To include your compound in the COVID-19 Resource Center, submit it here.

GS-504 nucleotide analog: Began Phase I/II trial

Gilead Sciences Inc. (GILD),

Read the full 46 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE